Cargando…

Bevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial

BACKGROUND: Brain metastases from breast cancer occur in 20%–40% of patients, and the frequency has increased over time. New radiosensitizers and cytotoxic or cytostatic agents, and innovative techniques of drug delivery are still under investigation. METHODS: Five patients with brain metastases who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Daigo, Iwase, Satoru, Tsubota, Yu, Sueoka, Noriko, Yamamoto, Chizuko, Kitamura, Kaoru, Odagiri, Hiroki, Nagumo, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459838/ https://www.ncbi.nlm.nih.gov/pubmed/23049262 http://dx.doi.org/10.2147/OTT.S36515

Ejemplares similares

The utility of hyperthermia for local recurrence of breast cancer
por: Yamamoto, Daigo, et al.
Publicado: (2012)

Simultaneous development of adenocarcinoma and gastrointestinal stromal tumor (GIST) in the stomach: case report
por: Yamamoto, Daigo, et al.
Publicado: (2012)

Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
por: Miyaji, Tempei, et al.
Publicado: (2017)

Intraocular bevacizumab in the treatment of choroidal metastases from breast cancer
por: Nadiminti, Kalyan, et al.
Publicado: (2016)

Effective Steroid Therapy for Reexpansion Pulmonary Edema
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2019)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
por: Leone, Jose Pablo, et al.
Publicado: (2020)

Chemotherapy with low-dose capecitabine as palliative treatment in a patient with metastatic breast cancer: a case report
por: Kawaguchi, Takashi, et al.
Publicado: (2009)

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
por: Yamamoto, Yutaka, et al.
Publicado: (2011)

Continued Exploration of Bevacizumab in Breast Cancer
por: Mehta, Rita S., et al.
Publicado: (2009)

Future role of bevacizumab in breast cancer
por: Conte, PF, et al.
Publicado: (2009)

The role of exosomal microRNAs; focus on clinical applications in breast cancer
por: Sueta, Aiko, et al.
Publicado: (2019)

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review
por: Yokoe, Takamichi, et al.
Publicado: (2017)

Surgical therapy for breast cancer liver metastases
por: Terata, Kaori, et al.
Publicado: (2020)

Diverticular Bleeding of the Colon during Combination Chemotherapy with Bevacizumab and Paclitaxel for Recurrent Breast Cancer
por: Nakayama, Yoshie, et al.
Publicado: (2013)

Bevacizumab resistance in breast cancer: are neuropilins the key?
por: Staton, CA, et al.
Publicado: (2008)

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
por: Yamamoto, Satoko, et al.
Publicado: (2013)

CPT-11/bevacizumab for the treatment of refractory brain metastases in patients with HER2–neu-positive breast cancer
por: Sengupta, S., et al.
Publicado: (2015)

Dramatic Improvement of Pulmonary Tumor Thrombotic Microangiopathy in a Breast Cancer Patient Treated With Bevacizumab
por: Kimura, Aki, et al.
Publicado: (2023)

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer
por: Hayashi, Mitsuhiro, et al.
Publicado: (2015)

Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report
por: Toyama, Yoichi, et al.
Publicado: (2012)

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence
por: Sueta, Aiko, et al.
Publicado: (2017)

Delayed and Synchronous Recurrence of Breast Cancer Metastases in Multiple Organs
por: Owaki, Takashi, et al.
Publicado: (2022)

Bevacizumab in the treatment of HER2-negative breast cancer
por: Lorusso, Vito
Publicado: (2008)

Bevacizumab in HER2-negative inflammatory breast cancer
por: Bertucci, François, et al.
Publicado: (2016)

Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature
por: Fujii, Yusuke, et al.
Publicado: (2018)

DDRE-07. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS
por: Ferraro, Gino, et al.
Publicado: (2021)

A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character
por: Hayashi, Mitsuhiro, et al.
Publicado: (2013)

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer
por: Shiota, Takuya, et al.
Publicado: (2016)

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer
por: Ogiya, Rin, et al.
Publicado: (2017)

Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases
por: Le Rhun, Emilie, et al.
Publicado: (2015)

Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
por: Chen, Tom Wei-Wu, et al.
Publicado: (2020)

Adjuvant Intravitreal Bevacizumab Injection for Choroidal and Orbital Metastases of Refractory Invasive Ductal Carcinoma of the Breast
por: Lin, I-Hung, et al.
Publicado: (2021)

First line targeted therapies in breast cancer: focus on bevacizumab
por: Milano, Amalia, et al.
Publicado: (2007)

The role of Xeloda in metastasic breast cancer
por: Cortés-Funes, H
Publicado: (2005)

Vulvar Cancer with Cutaneous and Breast Metastases
por: Adhikari, Nawaraj, et al.
Publicado: (2021)

Orbital Metastases of Breast Cancer in Males
por: Teodoru, Cosmin Adrian, et al.
Publicado: (2023)

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
por: Sueta, Aiko, et al.
Publicado: (2014)

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer
por: Takeshita, Takashi, et al.
Publicado: (2013)

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients
por: Takeshita, Takashi, et al.
Publicado: (2017)

Nodular Fasciitis of the Breast Mimicking Breast Cancer
por: Yamamoto, Shinya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nbgee8iherbtb1ovqnjcvuth6g